TOKYO, Feb. 3, 2026 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of ...

A large share of medicines developed today may never reach patients for a surprisingly simple reason: they cannot dissolve well enough in water.

XI'AN, SHAANXI PROVINCE, CHINA, January 20, 2026 /EINPresswire.com/ -- As global demand for clean-label, functional, ...

As we get into another winter holiday season, COVID is still part of our lives. And although it's hard to predict exactly what this year's cold, flu and coronavirus season will look like, experts want ...

President Trump's comments about restarting weapons tests are not likely to lead to mushroom-cloud explosions over the New Mexico desert or seismic shaking underground in Nevada, according to the ...

Washington — President Trump directed the Pentagon on Wednesday to resume testing of nuclear weapons "on an equal basis" with other countries' tests, possibly ending a decades-long U.S. pause that ...

Decision follows China's expansion of nuclear stockpile Kremlin reacts cautiously to Trump's nuclear remarks Russia's recent nuclear tests include Poseidon super torpedo Pentagon expects Chinese ...

GYEONGJU, South Korea — President Donald Trump said Wednesday he had instructed the Defense Department to “immediately” start testing nuclear weapons "on an equal basis" with other nations. “Because ...

Trump ordered the Pentagon to restart nuclear testing for the first time since 1992, citing rival nations’ actions. Trump’s claim that the U.S. has the largest arsenal contradicts data showing Russia ...

President Donald Trump on Thursday vowed to begin testing US nuclear weapons “on an equal basis” with Russia and China, heralding a potentially major shift in decades of US policy at a time of growing ...

President Trump explained the order by saying other, unnamed nations were testing their own nuclear weapons, even though no country has tested since 2017. By David E. Sanger and William J. Broad David ...

Sept 2 (Reuters) - Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and cheaper results, in line with an FDA push to reduce animal testing in ...